Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06846359 · ClinicalTrials.gov registry record · NA
Treatment of Upper Gastrointestinal Symptoms Using Hypnotherapy Sessions
A NA study of GI Symptoms, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06846359: Recruiting NA study of GI Symptoms, sponsored by Mayo Clinic.
NCT06846359 is a NA study of GI Symptoms that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06846359, a NA study of GI Symptoms, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate if hypnotherapy delivered digitally will help your GI symptoms.
Primary Outcome
The Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS) is a 5-item questionnaire that rates the severity of abdominal pain, number of days with abdominal pain, distention/bloating, bowel habits, and interference in quality of life. Each question has a possible score of 100 points. The total score can range from 0 - 500, with higher scores indicating greater severity of symptoms.
Conditions Studied
Interventions
- BEHAVIORAL Hypnotherapy
- BEHAVIORAL Educational module
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-02-20 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
What NCT06846359 shows while recruiting
NCT06846359 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with GI Symptoms appearing as the primary indexed condition, and to 2 interventions - of which Hypnotherapy is the first listed.
NCT06846359 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06846359 about?
NCT06846359 is a clinical study titled "Treatment of Upper Gastrointestinal Symptoms Using Hypnotherapy Sessions". The purpose of this research is to evaluate if hypnotherapy delivered digitally will help your GI symptoms.
What is the current status of trial NCT06846359?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-02-20. Estimated completion is 2027-02-01.
What conditions does trial NCT06846359 study?
This clinical trial studies the following conditions: GI Symptoms.
What interventions are being tested in trial NCT06846359?
The interventions under investigation include: Hypnotherapy (BEHAVIORAL), Educational module (BEHAVIORAL).
Who is sponsoring clinical trial NCT06846359?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06846359 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06846359's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI